RWD/RWE: From Theory to Real Cases. Online Event by DM RWE

On March 16, 2021, an online conference “Real-World Data/Real-World Evidence: from Theory to Implementation” will be held by DM RWE. The event agenda will cover current legislation, forecasts, and barriers, implemented cases and best practices showcasing RWE’s role in clinical research.

The event is organized by DM RWE, a Skolkovo Foundation resident and a member of the National Association of Biomedical Intelligence (NABI). The startup is a leading player which stimulates the integration of Real-World Evidence in the domestic market. At the event the company will present a case study with one of the largest unique oncology data ecosystems in Russia. The electronic data developed by DM RWE is already being used in a project which runs across nine European countries to study statistics over the past 30 years.

The event will be attended by industry experts, representatives of the scientific community, leaders in the field of clinical trials, representatives of pharmaceutical companies, regulatory bodies, as well as IT companies working with Big Data. The following speakers will be answering questions in panel sessions:

Vasily Ryazhenov, I.M. Sechenov First Moscow State Medical University. I.M. Sechenov Moscow State Medical University;

Mikhail Samsonov, Director of Medical Department, R-Pharm;

Tatiana Goldina, Head of Real Clinical Practice Data and Scientific Communication, Sanofi Russia;

Vadim Dumov, Head of Deep Analytics and Innovation Projects, Janssen Russia

Dmitry Ovchinnikov, Candidate of Biological Sciences, expert in Pharmaceutical Development, Director of Regulatory Affairs, AbbVie Russia and CIS

Boris Zingerman, General Director, NABI Association;

Alexander Panov, Head of Healthcare Practice, BGP Litigation;

Alexey Loleit, Chief Strategy and Product Officer, DM RWE.

Alexei Gurochkin, Medical Director, DM RWE.

The experts will share perspectives on big data trends, and demonstrate the relevance of RWD collection, RWE and its role in healthcare decision-making.

24 February 2021

Other news